M Grez

Author PubWeight™ 60.10‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science 1993 8.49
2 5'-Terminal sequences of eucaryotic mRNA can be cloned with high efficiency. Nucleic Acids Res 1981 8.10
3 Exons encode functional and structural units of chicken lysozyme. Proc Natl Acad Sci U S A 1980 4.01
4 Multiple mRNAs are generated from the chicken lysozyme gene. Cell 1981 2.46
5 HIV-1 strains from India are highly divergent from prototypic African and US/European strains, but are linked to a South African isolate. AIDS 1993 1.68
6 Functional analysis of a retroviral host-range mutant: altered long terminal repeat sequences allow expression in embryonal carcinoma cells. Proc Natl Acad Sci U S A 1987 1.68
7 Safety of retroviral gene marking with a truncated NGF receptor. Nat Med 2003 1.60
8 A role of Ia-associated invariant chains in antigen processing and presentation. Cell 1989 1.55
9 Synthesis of ds-cDNA involving addition of dCMP tails to allow cloning of 5'-terminal m RNA sequences. Methods Enzymol 1983 1.46
10 Expression of a chicken lysozyme recombinant gene is regulated by progesterone and dexamethasone after microinjection into oviduct cells. Cell 1982 1.37
11 Deduced amino acid sequence from the bovine oxytocin-neurophysin I precursor cDNA. Nature 1983 1.25
12 Determinants of retrovirus gene expression in embryonal carcinoma cells. J Virol 1991 1.21
13 Multiple regions of ETO cooperate in transcriptional repression. J Biol Chem 2001 1.18
14 Transgene optimization significantly improves SIN vector titers, gp91phox expression and reconstitution of superoxide production in X-CGD cells. Gene Ther 2008 1.11
15 Quantitative determination of lentiviral vector particle numbers by real-time PCR. Biotechniques 2001 1.09
16 Progress and prospects: gene therapy clinical trials (part 1). Gene Ther 2007 1.09
17 Structure of the lysozyme gene and expression in the oviduct and macrophages. Haematol Blood Transfus 1981 1.06
18 Physiological regulation of transgene expression by a lentiviral vector containing the A2UCOE linked to a myeloid promoter. Gene Ther 2011 1.06
19 Self-deleting retrovirus vectors for gene therapy. J Virol 1996 1.01
20 Specific hammerhead ribozyme-mediated cleavage of mutant N-ras mRNA in vitro and ex vivo. Oligoribonucleotides as therapeutic agents. J Biol Chem 1997 0.97
21 T cells for suicide gene therapy: activation, functionality and clinical relevance. J Immunol Methods 2007 0.93
22 A new PG13-based packaging cell line for stable production of clinical-grade self-inactivating gamma-retroviral vectors using targeted integration. Gene Ther 2009 0.93
23 Histone arginine methylation keeps RUNX1 target genes in an intermediate state. Oncogene 2012 0.93
24 High-dose multidrug resistance in primary human hematopoietic progenitor cells transduced with optimized retroviral vectors. Blood 1996 0.92
25 Efficient gene transfer into the CNS by lentiviral vectors purified by anion exchange chromatography. Gene Ther 2002 0.91
26 Kinetics of cell death in T lymphocytes genetically modified with two novel suicide fusion genes. Gene Ther 2003 0.91
27 Transient expression of the chicken lysozyme gene after transfer into human cells. EMBO J 1982 0.90
28 Retroviral vector integration in post-transplant hematopoiesis in mice conditioned with either submyeloablative or ablative irradiation. Gene Ther 2009 0.89
29 The transcription factor Sp1 regulates the myeloid-specific expression of the human hematopoietic cell kinase (HCK) gene through binding to two adjacent GC boxes within the HCK promoter-proximal region. J Biol Chem 1998 0.88
30 Retrovirally expressed anti-HIV ribozymes confer a selective survival advantage on CD4+ T cells in vitro. Gene Ther 2000 0.86
31 Correction of respiratory burst activity in X-linked chronic granulomatous cells to therapeutically relevant levels after gene transfer into bone marrow CD34+ cells. Hum Gene Ther 1998 0.85
32 Selection of HIV-1 genotypes by cultivation in different primary cells. AIDS 1999 0.84
33 A defined window for efficient gene marking of severe combined immunodeficient-repopulating cells using a gibbon ape leukemia virus-pseudotyped retroviral vector. Hum Gene Ther 2000 0.84
34 The isolation and characterization of the chicken lysozyme and ovomucoid gene. J Steroid Biochem 1980 0.83
35 High efficiency gene transfer to human hematopoietic SCID-repopulating cells under serum-free conditions. Blood 1998 0.82
36 Generation and characterization of human hematopoietic cell lines expressing factor VIII. J Hematother Stem Cell Res 2002 0.81
37 Kaposi's sarcoma in an Indian woman infected with HIV-1 and HIV-2. AIDS Res Hum Retroviruses 1993 0.79
38 Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms. Oncogene 2012 0.79
39 MDR1 gene expression in NOD/SCID repopulating cells after retroviral gene transfer under clinically relevant conditions. Mol Ther 2000 0.79
40 Distribution and infection of Langerhans cells in the skin of HIV-infected healthy subjects and AIDS patients. Res Virol 1993 0.78
41 Expression of the chicken lysozyme gene after transfer into homologous and heterologous cells. Prog Clin Biol Res 1982 0.75
42 [Effect of lactation on the weight and body composition of wet nurses]. Arch Latinoam Nutr 1983 0.75
43 High protective action against gamma radiation damage, by a tryptophan-ethanol mixture. Z Naturforsch B 1972 0.75
44 [Molecular mechanisms of hematopoietic stem cell differentiation]. Internist (Berl) 1995 0.75
45 Affinity chromatography of poly(A) polymerase on ATP-Sepharose. FEBS Lett 1977 0.75
46 Effective reversal of a transformed phenotype by retrovirus-mediated transfer of a ribozyme directed against mutant N-ras. Gene Ther 1998 0.75